Global Soft Implantable Drug Delivery System Market Growth 2025-2031

Publication ID:

LPI06258626

Publication Date:

June 11, 2025

Pages:

111

Publisher:

LPI

Countries:

Global [1]

USD 3,660.00

Medical Devices [2]

Pharma & Healthcare [3]

Description:

The global Soft Implantable Drug Delivery System market size is predicted to grow from US$ million in 2025 to US$ million in 2031; it is expected to grow at a CAGR of %from 2025 to 2031.
Soft implantable drug delivery systems typically refer to implantable devices or systems made from flexible, biocompatible materials that can deliver drugs or therapeutic substances in a controlled and sustained manner within the body.
United States market for Soft Implantable Drug Delivery System is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
China market for Soft Implantable Drug Delivery System is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
Europe market for Soft Implantable Drug Delivery System is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
Global key Soft Implantable Drug Delivery System players cover BD, B.Braun, AngioDynamics, Smiths Medical, Teleflex, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2024.
The 鈥淪oft Implantable Drug Delivery System Industry Forecast鈥� looks at past sales and reviews total world Soft Implantable Drug Delivery System sales in 2024, providing a comprehensive analysis by region and market sector of projected Soft Implantable Drug Delivery System sales for 2025 through 2031. With Soft Implantable Drug Delivery System sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Soft Implantable Drug Delivery System industry.
This Insight Report provides a comprehensive analysis of the global Soft Implantable Drug Delivery System landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Soft Implantable Drug Delivery System portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms鈥� unique position in an accelerating global Soft Implantable Drug Delivery System market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Soft Implantable Drug Delivery System and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Soft Implantable Drug Delivery System.
This report presents a comprehensive overview, market shares, and growth opportunities of Soft Implantable Drug Delivery System market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
Biodegradable Implants
Non-biodegradable Implants
Segmentation by Application:
Hospital
Clinic
Others
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the company's coverage, product portfolio, its market penetration.
BD
B.Braun
AngioDynamics
Smiths Medical
Teleflex
Medtronic
Districlass
Linhwa
Cook Medical
Fresenius
PFM Medical
Vygon
Key Questions Addressed in this Report
What is the 10-year outlook for the global Soft Implantable Drug Delivery System market?
What factors are driving Soft Implantable Drug Delivery System market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Soft Implantable Drug Delivery System market opportunities vary by end market size?
How does Soft Implantable Drug Delivery System break out by Type, by Application?

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Soft Implantable Drug Delivery System Annual Sales 2020-2031
2.1.2 World Current & Future Analysis for Soft Implantable Drug Delivery System by Geographic Region, 2020, 2024 & 2031
2.1.3 World Current & Future Analysis for Soft Implantable Drug Delivery System by Country/Region, 2020, 2024 & 2031
2.2 Soft Implantable Drug Delivery System Segment by Type
2.2.1 Biodegradable Implants
2.2.2 Non-biodegradable Implants
2.3 Soft Implantable Drug Delivery System Sales by Type
2.3.1 Global Soft Implantable Drug Delivery System Sales Market Share by Type (2020-2025)
2.3.2 Global Soft Implantable Drug Delivery System Revenue and Market Share by Type (2020-2025)
2.3.3 Global Soft Implantable Drug Delivery System Sale Price by Type (2020-2025)
2.4 Soft Implantable Drug Delivery System Segment by Application
2.4.1 Hospital
2.4.2 Clinic
2.4.3 Others
2.5 Soft Implantable Drug Delivery System Sales by Application
2.5.1 Global Soft Implantable Drug Delivery System Sale Market Share by Application (2020-2025)
2.5.2 Global Soft Implantable Drug Delivery System Revenue and Market Share by Application (2020-2025)
2.5.3 Global Soft Implantable Drug Delivery System Sale Price by Application (2020-2025)
3 Global by Company
3.1 Global Soft Implantable Drug Delivery System Breakdown Data by Company
3.1.1 Global Soft Implantable Drug Delivery System Annual Sales by Company (2020-2025)
3.1.2 Global Soft Implantable Drug Delivery System Sales Market Share by Company (2020-2025)
3.2 Global Soft Implantable Drug Delivery System Annual Revenue by Company (2020-2025)
3.2.1 Global Soft Implantable Drug Delivery System Revenue by Company (2020-2025)
3.2.2 Global Soft Implantable Drug Delivery System Revenue Market Share by Company (2020-2025)
3.3 Global Soft Implantable Drug Delivery System Sale Price by Company
3.4 Key Manufacturers Soft Implantable Drug Delivery System Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Soft Implantable Drug Delivery System Product Location Distribution
3.4.2 Players Soft Implantable Drug Delivery System Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 World Historic Review for Soft Implantable Drug Delivery System by Geographic Region
4.1 World Historic Soft Implantable Drug Delivery System Market Size by Geographic Region (2020-2025)
4.1.1 Global Soft Implantable Drug Delivery System Annual Sales by Geographic Region (2020-2025)
4.1.2 Global Soft Implantable Drug Delivery System Annual Revenue by Geographic Region (2020-2025)
4.2 World Historic Soft Implantable Drug Delivery System Market Size by Country/Region (2020-2025)
4.2.1 Global Soft Implantable Drug Delivery System Annual Sales by Country/Region (2020-2025)
4.2.2 Global Soft Implantable Drug Delivery System Annual Revenue by Country/Region (2020-2025)
4.3 Americas Soft Implantable Drug Delivery System Sales Growth
4.4 APAC Soft Implantable Drug Delivery System Sales Growth
4.5 Europe Soft Implantable Drug Delivery System Sales Growth
4.6 Middle East & Africa Soft Implantable Drug Delivery System Sales Growth
5 Americas
5.1 Americas Soft Implantable Drug Delivery System Sales by Country
5.1.1 Americas Soft Implantable Drug Delivery System Sales by Country (2020-2025)
5.1.2 Americas Soft Implantable Drug Delivery System Revenue by Country (2020-2025)
5.2 Americas Soft Implantable Drug Delivery System Sales by Type (2020-2025)
5.3 Americas Soft Implantable Drug Delivery System Sales by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Soft Implantable Drug Delivery System Sales by Region
6.1.1 APAC Soft Implantable Drug Delivery System Sales by Region (2020-2025)
6.1.2 APAC Soft Implantable Drug Delivery System Revenue by Region (2020-2025)
6.2 APAC Soft Implantable Drug Delivery System Sales by Type (2020-2025)
6.3 APAC Soft Implantable Drug Delivery System Sales by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Soft Implantable Drug Delivery System by Country
7.1.1 Europe Soft Implantable Drug Delivery System Sales by Country (2020-2025)
7.1.2 Europe Soft Implantable Drug Delivery System Revenue by Country (2020-2025)
7.2 Europe Soft Implantable Drug Delivery System Sales by Type (2020-2025)
7.3 Europe Soft Implantable Drug Delivery System Sales by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Soft Implantable Drug Delivery System by Country
8.1.1 Middle East & Africa Soft Implantable Drug Delivery System Sales by Country (2020-2025)
8.1.2 Middle East & Africa Soft Implantable Drug Delivery System Revenue by Country (2020-2025)
8.2 Middle East & Africa Soft Implantable Drug Delivery System Sales by Type (2020-2025)
8.3 Middle East & Africa Soft Implantable Drug Delivery System Sales by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Soft Implantable Drug Delivery System
10.3 Manufacturing Process Analysis of Soft Implantable Drug Delivery System
10.4 Industry Chain Structure of Soft Implantable Drug Delivery System
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Soft Implantable Drug Delivery System Distributors
11.3 Soft Implantable Drug Delivery System Customer
12 World Forecast Review for Soft Implantable Drug Delivery System by Geographic Region
12.1 Global Soft Implantable Drug Delivery System Market Size Forecast by Region
12.1.1 Global Soft Implantable Drug Delivery System Forecast by Region (2026-2031)
12.1.2 Global Soft Implantable Drug Delivery System Annual Revenue Forecast by Region (2026-2031)
12.2 Americas Forecast by Country (2026-2031)
12.3 APAC Forecast by Region (2026-2031)
12.4 Europe Forecast by Country (2026-2031)
12.5 Middle East & Africa Forecast by Country (2026-2031)
12.6 Global Soft Implantable Drug Delivery System Forecast by Type (2026-2031)
12.7 Global Soft Implantable Drug Delivery System Forecast by Application (2026-2031)
13 Key Players Analysis
13.1 BD
13.1.1 BD Company Information
13.1.2 BD Soft Implantable Drug Delivery System Product Portfolios and Specifications
13.1.3 BD Soft Implantable Drug Delivery System Sales, Revenue, Price and Gross Margin (2020-2025)
13.1.4 BD Main Business Overview
13.1.5 BD Latest Developments
13.2 B.Braun
13.2.1 B.Braun Company Information
13.2.2 B.Braun Soft Implantable Drug Delivery System Product Portfolios and Specifications
13.2.3 B.Braun Soft Implantable Drug Delivery System Sales, Revenue, Price and Gross Margin (2020-2025)
13.2.4 B.Braun Main Business Overview
13.2.5 B.Braun Latest Developments
13.3 AngioDynamics
13.3.1 AngioDynamics Company Information
13.3.2 AngioDynamics Soft Implantable Drug Delivery System Product Portfolios and Specifications
13.3.3 AngioDynamics Soft Implantable Drug Delivery System Sales, Revenue, Price and Gross Margin (2020-2025)
13.3.4 AngioDynamics Main Business Overview
13.3.5 AngioDynamics Latest Developments
13.4 Smiths Medical
13.4.1 Smiths Medical Company Information
13.4.2 Smiths Medical Soft Implantable Drug Delivery System Product Portfolios and Specifications
13.4.3 Smiths Medical Soft Implantable Drug Delivery System Sales, Revenue, Price and Gross Margin (2020-2025)
13.4.4 Smiths Medical Main Business Overview
13.4.5 Smiths Medical Latest Developments
13.5 Teleflex
13.5.1 Teleflex Company Information
13.5.2 Teleflex Soft Implantable Drug Delivery System Product Portfolios and Specifications
13.5.3 Teleflex Soft Implantable Drug Delivery System Sales, Revenue, Price and Gross Margin (2020-2025)
13.5.4 Teleflex Main Business Overview
13.5.5 Teleflex Latest Developments
13.6 Medtronic
13.6.1 Medtronic Company Information
13.6.2 Medtronic Soft Implantable Drug Delivery System Product Portfolios and Specifications
13.6.3 Medtronic Soft Implantable Drug Delivery System Sales, Revenue, Price and Gross Margin (2020-2025)
13.6.4 Medtronic Main Business Overview
13.6.5 Medtronic Latest Developments
13.7 Districlass
13.7.1 Districlass Company Information
13.7.2 Districlass Soft Implantable Drug Delivery System Product Portfolios and Specifications
13.7.3 Districlass Soft Implantable Drug Delivery System Sales, Revenue, Price and Gross Margin (2020-2025)
13.7.4 Districlass Main Business Overview
13.7.5 Districlass Latest Developments
13.8 Linhwa
13.8.1 Linhwa Company Information
13.8.2 Linhwa Soft Implantable Drug Delivery System Product Portfolios and Specifications
13.8.3 Linhwa Soft Implantable Drug Delivery System Sales, Revenue, Price and Gross Margin (2020-2025)
13.8.4 Linhwa Main Business Overview
13.8.5 Linhwa Latest Developments
13.9 Cook Medical
13.9.1 Cook Medical Company Information
13.9.2 Cook Medical Soft Implantable Drug Delivery System Product Portfolios and Specifications
13.9.3 Cook Medical Soft Implantable Drug Delivery System Sales, Revenue, Price and Gross Margin (2020-2025)
13.9.4 Cook Medical Main Business Overview
13.9.5 Cook Medical Latest Developments
13.10 Fresenius
13.10.1 Fresenius Company Information
13.10.2 Fresenius Soft Implantable Drug Delivery System Product Portfolios and Specifications
13.10.3 Fresenius Soft Implantable Drug Delivery System Sales, Revenue, Price and Gross Margin (2020-2025)
13.10.4 Fresenius Main Business Overview
13.10.5 Fresenius Latest Developments
13.11 PFM Medical
13.11.1 PFM Medical Company Information
13.11.2 PFM Medical Soft Implantable Drug Delivery System Product Portfolios and Specifications
13.11.3 PFM Medical Soft Implantable Drug Delivery System Sales, Revenue, Price and Gross Margin (2020-2025)
13.11.4 PFM Medical Main Business Overview
13.11.5 PFM Medical Latest Developments
13.12 Vygon
13.12.1 Vygon Company Information
13.12.2 Vygon Soft Implantable Drug Delivery System Product Portfolios and Specifications
13.12.3 Vygon Soft Implantable Drug Delivery System Sales, Revenue, Price and Gross Margin (2020-2025)
13.12.4 Vygon Main Business Overview
13.12.5 Vygon Latest Developments
14 Research Findings and Conclusion

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.

91制片厂